{"id":173422,"date":"2023-01-09T15:21:42","date_gmt":"2023-01-09T22:21:42","guid":{"rendered":"https:\/\/inbusinessphx.com\/?p=173422"},"modified":"2023-01-09T15:21:42","modified_gmt":"2023-01-09T22:21:42","slug":"phoenix-facility-opens-is-first-in-u-s-to-increase-manufacturing-of-diagnostics-and-life-sciences-products","status":"publish","type":"post","link":"https:\/\/staging.inbusinessphx.com\/?p=173422","title":{"rendered":"Phoenix Facility\u00a0Is First to Open in U.S. to Increase Manufacturing\u00a0of\u00a0Diagnostics\u00a0and\u00a0Life Sciences Products"},"content":{"rendered":"<p>Being committed to continued advances in improving human health, SCHOTT has opened a new facility in Phoenix, Arizona, to expand the development and manufacturing of diagnostics\u00a0and life science\u00a0consumables. Launching the first fully integrated microfluidic foundry in the United States validates\u00a0<a href=\"https:\/\/www.businesswire.com\/news\/home\/20220121005051\/en\/Increased-Sales-and-Optimized-Footprint-Highlight-SCHOTT%E2%80%99s-U.S.-Growth-in-2021\" target=\"_blank\" rel=\"noopener\">SCHOTT\u2019s global growth<\/a> plan and increases production capabilities to help get these products to market faster and more efficiently.<\/p>\n<p>The new,almost\u00a040,000-square-foot facility, comprising\u00a0of\u00a0clean room,high volume manufacturing of microarrays and microfluidic devices, allows the company to onshore critical manufacturing\u00a0<a href=\"https:\/\/www.whitehouse.gov\/briefing-room\/statements-releases\/2022\/02\/24\/the-biden-harris-plan-to-revitalize-american-manufacturing-and-secure-critical-supply-chains-in-2022\/\" target=\"_blank\" rel=\"noopener\">supporting the\u00a0U.S. Government\u2019s renewed interest<\/a>\u00a0in reshoring and\u00a0revitalizing\u00a0American manufacturing\u00a0to\u00a0secure critical\u00a0domestic\u00a0supply chains. At the grand opening event on January 9, 2023, speakers from SCHOTT, state, and local government officials, and prominent members of the Phoenix biotech community highlighted the significance of SCHOTT expanding in the U.S.<\/p>\n<p>\u201cThe\u00a0United States is one of our most important markets, and we are pleased to expand our\u00a0R&amp;D\u00a0and production facilities in this region\u201d said Dr. Heinz Kaiser, a member of SCHOTT\u2019s management board. \u201cEnhancing our global footprint with a manufacturing base in Phoenix not only expands our reach, but also\u00a0caters to the fast-growing and dynamic diagnostics market in\u00a0North America. We are eager to build a unique pipeline for this market in the U.S.\u201d<\/p>\n<p><a href=\"https:\/\/schott-minifab.com\/\" target=\"_blank\" rel=\"noopener\">SCHOTT MINIFAB<\/a>\u00a0officially\u00a0opened the new facility todayduring an event on-site, located at\u00a04217 E Cotton Center Blvd. Phoenix, AZ 85040. SCHOTT executives were joined by Phoenix\u00a0Mayor Kate Gallego\u00a0(D)\u00a0and Arizona State Democratic Whip Marcelino\u00a0Qui\u00f1onez\u00a0(D),\u00a0as well members\u00a0from both\u00a0The Office of Senator Mark Kelly (D-AZ)\u00a0and\u00a0The Office of Congressman Reuben Gallego (D-AZ).<\/p>\n<p>Phoenix,\u00a0AZ\u00a0will mark SCHOTT\u2019s third\u00a0diagnostics\u00a0location, with other centers of excellence located in Jena, Germany, and Melbourne, Australia. However, this will be the first location to place a special\u00a0emphasis\u00a0on\u00a0bioscience capabilities using high-density microarrays for diagnostic and life science research.\u00a0Over the next few years, it will create 150 jobs in the greater Phoenix area, growing SCHOTT MINIFAB\u2019s employee base\u00a0in Phoenix\u00a0by 300 percent.<\/p>\n<p>Diagnostic tests for infectious disease, autoimmune disease and cancers are increasingly being performed at the Point of Care (PoC) rather than central laboratories. Demand especially took off during the COVID-19 pandemic.\u00a0These tests, in various microfluidic cartridges with embedded biosensors, detect and quantify multiple biomarkers related to the genes and proteins of the infecting agent or present in the patient.<\/p>\n<p>The new field of Precision Medicine enables the precise diagnosis and better treatment outcomes of disease, considering the patient\u2019s individual genetic makeup, environment, and lifestyle. Enabling companies producing leading edge life science research tools, and\u00a0advanced diagnostics which probe the details of genomic and proteomic signatures associated with disease, has become a major strategic focus area for SCHOTT.<\/p>\n<p>\u201cMicrofluidic consumables have grown more popular due to the global pandemic, and solutions will need to be more complex in order to better serve patients\u2019 needs,\u201d said Greg Wolters,\u00a0Head of Strategic Business Field Diagnostics at SCHOTT. \u201cBioscience is the key component to making that happen, and it starts with utilizing microarrays. SCHOTT MINIFAB wants to empower its clients at every stage of product development to bring their\u00a0ideas to fruition, and ultimately change the world. This facility allows us to partner with even more clients in the United States and domestically produce diagnostic devices that can improve patient outcomes.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Being committed to continued advances in improving human health, SCHOTT has opened a new facility in Phoenix, Arizona, to expand the development and manufacturing of diagnostics\u00a0and life science\u00a0consumables. Launching the first fully integrated microfluidic foundry in the United States validates\u00a0SCHOTT\u2019s global growth plan and increases production capabilities to help get these products to market faster [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-173422","post","type-post","status-publish","format-standard","hentry","category-growth-enterprise"],"_links":{"self":[{"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=\/wp\/v2\/posts\/173422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=173422"}],"version-history":[{"count":0,"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=\/wp\/v2\/posts\/173422\/revisions"}],"wp:attachment":[{"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=173422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=173422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/staging.inbusinessphx.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=173422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}